DK175574B1 - DNA-sekvens, der koder for et specifikt protein, rekombinantvektor, der omfatter sekvensen, og celler, der er transficerede til ekspression af proteinet, samt fremgangsmåde til fremstilling af proteinet - Google Patents

DNA-sekvens, der koder for et specifikt protein, rekombinantvektor, der omfatter sekvensen, og celler, der er transficerede til ekspression af proteinet, samt fremgangsmåde til fremstilling af proteinet Download PDF

Info

Publication number
DK175574B1
DK175574B1 DK198603085A DK308586A DK175574B1 DK 175574 B1 DK175574 B1 DK 175574B1 DK 198603085 A DK198603085 A DK 198603085A DK 308586 A DK308586 A DK 308586A DK 175574 B1 DK175574 B1 DK 175574B1
Authority
DK
Denmark
Prior art keywords
protein
sequence
dna
expression
host cell
Prior art date
Application number
DK198603085A
Other languages
Danish (da)
English (en)
Other versions
DK308586A (da
DK308586D0 (da
Inventor
Donald C Foster
Mark J Murray
Kathleen L Berkner
Earl W Davie
Original Assignee
Univ Washington
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27115147&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK175574(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/766,109 external-priority patent/US4968626A/en
Application filed by Univ Washington, Zymogenetics Inc filed Critical Univ Washington
Publication of DK308586D0 publication Critical patent/DK308586D0/da
Publication of DK308586A publication Critical patent/DK308586A/da
Application granted granted Critical
Publication of DK175574B1 publication Critical patent/DK175574B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK198603085A 1985-06-27 1986-06-27 DNA-sekvens, der koder for et specifikt protein, rekombinantvektor, der omfatter sekvensen, og celler, der er transficerede til ekspression af proteinet, samt fremgangsmåde til fremstilling af proteinet DK175574B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74960085A 1985-06-27 1985-06-27
US74960085 1985-06-27
US06/766,109 US4968626A (en) 1985-08-15 1985-08-15 DNA sequence coding for protein C
US76610985 1985-08-15

Publications (3)

Publication Number Publication Date
DK308586D0 DK308586D0 (da) 1986-06-27
DK308586A DK308586A (da) 1986-12-28
DK175574B1 true DK175574B1 (da) 2004-12-13

Family

ID=27115147

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198603085A DK175574B1 (da) 1985-06-27 1986-06-27 DNA-sekvens, der koder for et specifikt protein, rekombinantvektor, der omfatter sekvensen, og celler, der er transficerede til ekspression af proteinet, samt fremgangsmåde til fremstilling af proteinet

Country Status (7)

Country Link
EP (1) EP0215548B2 (de)
JP (2) JP2614848B2 (de)
AT (1) ATE93272T1 (de)
CA (1) CA1341228C (de)
DE (1) DE3688900T3 (de)
DK (1) DK175574B1 (de)
NO (1) NO305660B1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
US5550036A (en) 1986-04-09 1996-08-27 Eli Lilly And Company Method for co-amplification of human protein C genes in human cells
USH1148H (en) 1987-04-17 1993-03-02 Method of separating activated human protein C
JP2799316B2 (ja) * 1987-06-12 1998-09-17 ヘキスト・マリオン・ルセル株式会社 雑種ヒトプロテインｃおよびその遺伝子工学的製法
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
US5196322A (en) * 1987-12-28 1993-03-23 Eli Lilly And Company Vectors and compounds for expression of zymogen forms of human protein C
JP2728240B2 (ja) * 1988-07-26 1998-03-18 ヘキスト薬品工業株式会社 ヒトプロテインｃ変異体及びその製造方法
CA1332049C (en) * 1988-10-07 1994-09-20 Eli Lilly And Company Eukaryotic expression
JP3045307B2 (ja) * 1989-08-11 2000-05-29 ザイモジェネティクス，インコーポレイティド 活性化プロテインｃを生成するための細胞培養法
JP2774156B2 (ja) * 1989-09-05 1998-07-09 帝人株式会社 ヒトプロテインｃおよび／または活性化ヒトプロテインｃ様活性を有する蛋白
JP2774163B2 (ja) * 1989-11-14 1998-07-09 帝人株式会社 ヒトプロテインｃ様活性を有する蛋白
US5358932A (en) * 1989-12-29 1994-10-25 Zymogenetics, Inc. Hybrid protein C
ES2113878T3 (es) * 1989-12-29 1998-05-16 Zymogenetics Inc Proteina c hibrida.
IL97311A0 (en) * 1990-02-23 1992-05-25 Lilly Co Eli Vectors and compounds for expression of glycosylation mutants of human protein c
US5270178A (en) * 1990-02-23 1993-12-14 Eli Lilly And Company Vectors and compounds for expression of zymogen forms of human protein C
AT402263B (de) * 1991-06-20 1997-03-25 Immuno Ag Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
JPH08508875A (ja) * 1992-05-01 1996-09-24 帝人株式会社 蛋白分泌細胞の流加回分培養法
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5561053A (en) * 1994-08-05 1996-10-01 Genentech, Inc. Method for selecting high-expressing host cells
JP2003514545A (ja) * 1999-11-19 2003-04-22 イーライ・リリー・アンド・カンパニー プロテインｃ誘導体
AP2007004253A0 (en) * 2005-05-24 2007-12-31 Avestha Gengraine Tech Pvt Ltd A process comprising codon optimization for the production of recombinant activated human protein C for the treatment of sepsis
EP2911579B1 (de) 2012-10-23 2020-12-09 Koninklijke Philips N.V. Belastungsmesssystem

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327860D0 (en) * 1983-10-18 1983-11-16 Fujisawa Pharmaceutical Co Monoclonal antiprotein c antibody
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C

Also Published As

Publication number Publication date
NO862601L (no) 1986-12-29
JPH09107976A (ja) 1997-04-28
DE3688900T3 (de) 1998-06-10
NO305660B1 (no) 1999-07-05
EP0215548B1 (de) 1993-08-18
EP0215548A1 (de) 1987-03-25
CA1341228C (en) 2001-05-15
DK308586A (da) 1986-12-28
NO862601D0 (no) 1986-06-27
DK308586D0 (da) 1986-06-27
DE3688900D1 (de) 1993-09-23
ATE93272T1 (de) 1993-09-15
DE3688900T2 (de) 1993-12-09
JPS62111690A (ja) 1987-05-22
EP0215548B2 (de) 1998-01-07
JP2614848B2 (ja) 1997-05-28
JP2688407B2 (ja) 1997-12-10

Similar Documents

Publication Publication Date Title
DK175574B1 (da) DNA-sekvens, der koder for et specifikt protein, rekombinantvektor, der omfatter sekvensen, og celler, der er transficerede til ekspression af proteinet, samt fremgangsmåde til fremstilling af proteinet
DK175183B1 (da) DNA-sekvens, der koder for et protein med i alt væsentligt samme biologiske aktivitet som humanprotein C, ekspressionsvektor og pattedyrsceller indeholdende DNA-sekvensen, samt fremgangsmåde til fremstilling af proteinet
US5225537A (en) Methods for producing hybrid phospholipid-binding proteins
US5516650A (en) Production of activated protein C
DK175616B1 (da) Ekspression af faktor VII aktiviteter i pattedyrceller
EP0319312B1 (de) Für die direkte Expression von aktiviertem menschlichen Protein-C verwendbare Vektoren und Zusammensetzungen
Bugge et al. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction.
US4740461A (en) Vectors and methods for transformation of eucaryotic cells
CA2099562C (en) Expression of active human protein c in mammary tissue of transgenic animals
US5302529A (en) Plasmid coding for human protein C
US5648253A (en) Inhibitor-resistant urokinase
EP0485504B1 (de) Zellenzuchtverfahren für die produktion von aktiviertem protein-c
Sun et al. Gene targeting in hemostasis. Prothrombin
US5079159A (en) Method for making tissue plasminogen activator
USRE38981E1 (en) DNA sequence coding for protein C
WO1991009951A2 (en) Recombinant protein c with truncated light chain
Velander Expression of human protein C in mammary tissue of transgenic mammals

Legal Events

Date Code Title Description
PUP Patent expired